Organization: Ontario Ministry of Research and Innovation

Nuclear materials testing laboratory set to open

A new $17-million Reactor Materials Testing Laboratory (RMTL) at Queen’s Univ is awaiting final commissioning this year to assist in advancing the safety and economy of nuclear power. The facility uses a proton accelerator to test materials for stress and temperature when inside a nuclear reactor that could lead to design changes to make them…

SGC launches third phase with $49.9 million in funding

The Toronto-based Structural Genomics Consortium (SGC) has received $48.9 million to launch its third four-year phase. The funding is 30% less than in previous phases due primarily to the closure of the SGC laboratory at Karolinska Institutet in suburban Stockholm last June. The funding — 45% of which comes from commercial entities — will support…

Xogen deploys waste water treatment technology

Xogen Technologies is taking its patented waste water treatment technology to the global market following the successful deployment of a pilot plant in its home town of Orangeville ON. The company’s technology not only treats waste water to regulated requirements but it also removes pharmaceutical and personal care products to below detectable levels and generates…

Sick Kids robotic arm project receives another $10 million

The federal government is contributing $10 million to a project at The Hospital for Sick Kids in Toronto to develop an image-guided robotic surgical arm designed for paediatric patients. The $29- million project, dubbed KidsArm, is expected to have commercial benefits either through new start-ups or other revenue-generating activities. The funding through the Federal Economic…

ICAV receives $2 million in Ontario funding

The Ontario Ministry of Research and Innovation is investing $2 million in the International Consortium on Anti-Virals, (ICAV) an emerging consortium based at Trent Univ in Peterborough ON. The funding matches a federal contribution last year and is designed to accelerate ICAV’s discovery and commercialization of new anti-virals. In related news, the Greater Peterborough Region…

Structural Genomics Consortium funding announced

Complete funding for the second phase of the Structural Genomics Consortium has been announced, with 13 partners (including three pharmaceutical firms) providing more than $105 million. The consortium — led by Dr Aled Edwards at the Univ of Toronto with three nodes in Toronto, the Univ of Oxford and the Karolinska Institutet — is dedicated…